|The Kana n/a (Catalog #MBS7041616) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Kanamycin can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunochromatography, Immune colloidal gold and other possible application.
ELISA: IC50?2ppb; Detect Range: 0.5-40.5ppb. Researchers should empirically determine the suitability of the Kana n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The Kana n/a product has the following accession number(s) (GI #28207672) (NCBI Accession #AAO32126.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal to Kanamycin.
Antibody Type: IgG1. Note: Applications are user defined. Product is developed as raw material and quality control tested in house, data is not provided on the data sheet. The researcher needs to establish and confirm the suitability of the product for their application.
Testing data may be available for this product regarding applications and assays the lab developed, please inquire. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Kana are readily searchable from our website. Different antibodies against the same target such as Kana may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.